Guardant Health Capital Expenditures (CapEx) Growth & History (GH)
Guardant Health's capital expenditures (capex) was $48.3M for fiscal 2025.
View full Guardant Health company overviewGuardant Health annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $48.3M | $13.2M | +37.68% |
| 2024 | 2024-12-31 | $35.1M | $14.6M | +71.26% |
| 2023 | 2023-12-31 | $20.5M | −$57.0M | −73.55% |
| 2022 | 2022-12-31 | $77.5M | $2.4M | +3.23% |
| 2021 | 2021-12-31 | $75.0M | $38.9M | +107.43% |
| 2020 | 2020-12-31 | $36.2M | $17.5M | +93.26% |
| 2019 | 2019-12-31 | $18.7M | −$1.5M | −7.36% |
| 2018 | 2018-12-31 | $20.2M | $13.5M | +202.39% |
| 2017 | 2017-12-31 | $6.7M | — | — |
Guardant Health quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $11.8M | $6.1M | +108.16% |
| Q1 2026 | 2026-03-31 | $5.6M | $1.1M | +25.14% |
| Q4 2025 | 2025-12-31 | $27.8M | $9.0M | +47.54% |
| Q3 2025 | 2025-09-30 | $10.3M | $6.2M | +146.49% |
| Q2 2025 | 2025-06-30 | $5.6M | $572,000 | +11.27% |
| Q1 2025 | 2025-03-31 | $4.5M | −$2.5M | −35.69% |
| Q4 2024 | 2024-12-31 | $18.9M | $14.8M | +362.96% |
| Q3 2024 | 2024-09-30 | $4.2M | $1.8M | +77.02% |
| Q2 2024 | 2024-06-30 | $5.1M | −$1.4M | −22.05% |
| Q1 2024 | 2024-03-31 | $6.9M | −$590,000 | −7.84% |
| Q4 2023 | 2023-12-31 | $4.1M | −$5.9M | −59.23% |
| Q3 2023 | 2023-09-30 | $2.4M | −$19.4M | −89.08% |
| Q2 2023 | 2023-06-30 | $6.5M | −$16.5M | −71.72% |
| Q1 2023 | 2023-03-31 | $7.5M | −$15.2M | −66.85% |
| Q4 2022 | 2022-12-31 | $10.0M | −$14.6M | −59.39% |
| Q3 2022 | 2022-09-30 | $21.7M | −$423,000 | −1.91% |
| Q2 2022 | 2022-06-30 | $23.0M | $4.4M | +23.34% |
| Q1 2022 | 2022-03-31 | $22.7M | $13.1M | +136.80% |
| Q4 2021 | 2021-12-31 | $24.6M | $17.3M | +238.16% |
| Q3 2021 | 2021-09-30 | $22.1M | $12.4M | +126.33% |
| Q2 2021 | 2021-06-30 | $18.7M | $9.2M | +96.43% |
| Q1 2021 | 2021-03-31 | $9.6M | −$12,000 | −0.13% |
| Q4 2020 | 2020-12-31 | $7.3M | $193,000 | +2.72% |
| Q3 2020 | 2020-09-30 | $9.8M | $3.9M | +66.54% |
| Q2 2020 | 2020-06-30 | $9.5M | $6.5M | +212.01% |
| Q1 2020 | 2020-03-31 | $9.6M | $6.9M | +254.82% |
| Q4 2019 | 2019-12-31 | $7.1M | $4.2M | +141.86% |
| Q3 2019 | 2019-09-30 | $5.9M | −$36,000 | −0.61% |
| Q2 2019 | 2019-06-30 | $3.0M | −$4.3M | −58.48% |
| Q1 2019 | 2019-03-31 | $2.7M | −$1.3M | −32.73% |
| Q4 2018 | 2018-12-31 | $2.9M | — | — |
| Q3 2018 | 2018-09-30 | $5.9M | — | — |
| Q2 2018 | 2018-06-30 | $7.3M | — | — |
| Q1 2018 | 2018-03-31 | $4.0M | — | — |
Guardant Health capital expenditures (capex) trends
Over the last five fiscal years, Guardant Health's capital expenditures (capex) increased from $36.2M to $48.3M, a change of $12.1M. The latest reported quarter, Q2 2026, shows $11.8M.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Guardant Health source filings ↗